Unilever eyes GSK's consumer goods arm in possible 50 billion-pound deal. Unilever confirms interest in GSK assets. GSK consumer business would be "strong strategic fit" Sunday Times says 50bn-pound bid rejected in late 2021 for GSK.

GSK declined to comment on the approach. GSK: "We have no comment on this matter at this time" GSK is the world's second largest drug maker, with sales of more than $30 billion a year in the U.S. and around the world.

GSK and Pfizer rejected Unilever's bid for the company. The offer did not include any takeover premium or recognition of synergies. The deal is expected to be completed by the end of the year, according to reports in the Sunday Times and the Mail on Sunday.
Tap to copy the Short Url to this post: 
All Business News on a Single Page. Join for Free →